A putative target for the anti-colorectal cancer action of nonsteroidal ant
i-inflammatory drugs is the inducible isoform of cyclooxygenase (COX), COX-
2. COX-2 is expressed within intestinal adenomas in murine polyposis models
, but expression has been poorly characterized in human colorectal neoplasm
s. Therefore, we investigated the localization of the COX-2 protein in huma
n sporadic colorectal adenomas, Immunohistochemistry for COX-2 and CD68 (a
tissue macrophage marker) was performed on formalin-fixed, paraffin-embedde
d (n = 52) and frozen, acetone-fixed (n = 6) sections of human sporadic col
orectal adenomas, Forty of 52 (77%) formalin-fixed adenomas expressed immun
oreactive COX-2. COX-2 was localized to superficial interstitial macrophage
s in 39 cases (75%) and to deep interstitial macrophages in 9 cases (17%).
COX-2 staining of dysplastic epithelial cells was observed in 15 cases (29%
). A logistic regression analysis identified the adenoma site (P = 0.012) a
nd histological type (P = 0.001) as independent predictors of superficial m
acrophage COX-2 expression. There was no relationship between the number of
macrophages within an adenoma and macrophage COX-2 expression. These resul
ts indicate that COX-2 is expressed predominantly by interstitial macrophag
es within human sporadic colorectal adenomas, If COX-2 does indeed play a r
ole in the early stages of colorectal carcinogenesis in man, these data sug
gest COX-2-mediated paracrine signaling between the macrophages and epithel
ial cells within adenomas.